ArticleContemporary clinical trials communications2024

A prospective randomized controlled study of multi-intravenous infusion of umbilical cord mesenchymal stem cells in patients with heart failure and reduced ejection fraction (PRIME-HFrEF) trial: Rationale and design.

Xin Gong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.